Results 211 to 220 of about 130,154 (269)

Family-Related Factors in Children and Adolescents With Chronic Pain: A Systematic Review. [PDF]

Eur J Pain
Martí L, Garriga-Cazorla H, Roman-Juan J, Miró J.   +3 more
europepmc   +1 more source

Developing the Inpatient Mental Health Pharmaceutical Assessment and Care Tool (IMPACT) for use by UK mental health pharmacy teams—a modified Delphi study

British Journal of Clinical Pharmacology, EarlyView.
Aims To develop an evidence‐ and consensus‐based patient prioritization tool for use by UK mental health inpatient pharmacy teams. Methods A modified‐Delphi technique was used to obtain experts' agreement on the content, design and practical use of the patient prioritization tool.
Fatima Q. Alshaikhmubarak, Richard N. Keers, Petra Brown, Penny J. Lewis   +3 more
wiley   +1 more source

Brain MRI volumetry and atrophy rating scales as predictors of amyloid status and eligibility for anti-amyloid treatment in a real-world memory clinic setting. [PDF]

J Neurol
Zilioli A, Rosenberg A, Mohanty R, Matton A, Granberg T, Hagman G, Lötjönen J, Kivipelto M, Westman E.   +8 more
europepmc   +1 more source

Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activity

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Prednisone is a widely used glucocorticoid in the treatment of lupus, although its dosing is often determined empirically. Prednisolone, the active metabolite of prednisone, is found in its free form in the serum. The goal of this study was to develop a population pharmacokinetic model in patients with systemic lupus erythematosus (SLE ...
Naïm Bouazza, Michaela Semeraro, Gabrielle Lui, Léo Froelicher‐Bournaud, Laure Choupeaux, Jean‐Marc Treluyer, Sihem Benaboud, Joelle Terzic, Eric Hachulla, Philippe Remy, Jérôme Harambat, Alexandre Karras, Caroline Rousset‐Rouviere, Anne Jolivot, Zahir Amoura, Eric Daugas, Aurélie Hummel, Rémi Salomon, Jean‐Christophe Lega, Stéphane Decramer, Alexandre Belot, Delphine Gobert, Nathalie Costedoat‐Chalumeau, Stanislas Faguer, Isabelle Melki, Noémie Jourde‐Chiche, Brigitte Bader‐Meunier   +26 more
wiley   +1 more source

Non-response to short-term ketamine use for treatment-resistant depression. [PDF]

Pharmacol Rep
Walaszek M, Cubała WJ, Kachlik Z, Pastuszak M, Pastuszak K, Kwaśny A.   +5 more
europepmc   +1 more source

Expert insight into the education of healthcare professionals on medication adherence

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Medication non‐adherence is a global health problem affecting patients with numerous medical conditions. Training healthcare professionals (HCPs) on managing the challenging issue of medication non‐adherence requires an evidence‐based approach.
Fatima Rezae, Stephen Carter, Rebekah Moles, Ayano Kelly   +3 more
wiley   +1 more source

Psychiatric symptoms in stroke patients: Clinical features of depression and anxiety. [PDF]

World J Psychiatry
Li JM, Long SS, Lu TX, Jiang YC, Zhang XW, Ren YQ.   +5 more
europepmc   +1 more source

The use of international classification of diseases codes to identify hospital admissions linked with adverse drug events: Validation study

British Journal of Clinical Pharmacology, EarlyView.
Aims Several methods exist to identify hospital admissions related to adverse drug events (ADEs). Clinical adjudication by healthcare professionals is the gold standard but is labour‐intensive. Spontaneous reporting and routinely collected healthcare data using a set of International Classification of Diseases (ICD) codes often underestimate the ...
Zuzana Juhásová, Fatma Karapinar‐Çarkit, Daniala L. Weir   +2 more
wiley   +1 more source

Social functioning in bipolar disorder: investigating the role played by comorbid physical illnesses and cognition. [PDF]

Dement Neuropsychol
Pereira IMB, Mantovani LM, Frota GA, Wenceslau RR, Matos JC, Cruz BF, Teixeira AL, Barbosa IG.   +7 more
europepmc   +1 more source

External validation of a therapeutic window for risperidone in children with autism spectrum disorder

British Journal of Clinical Pharmacology, EarlyView.
Abstract Although risperidone is an effective pharmacological intervention for managing disruptive behaviour in children with autism spectrum disorder, it may induce metabolic side effects. This study aimed to externally validate the population pharmacokinetic (popPK) model and the therapeutic window of 3.5–7 ng/mL of risperidone and 9‐OH‐risperidone ...
Rebecca A. Hermans, Kathalijne Bruens, Karin M. Egberts, Birgit C. P. Koch, Bram Dierckx, Manon H. J. Hillegers, Marcel Romanos, Regina Taurines, Stefanie Fekete, Khatia Eisenecker, Hans‐Willi Clement, Christian Fleischhaker, Brenda C. M. de Winter   +12 more
wiley   +1 more source